WBA Stock Overview
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 2/6 |
Walgreens Boots Alliance, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$6,496.50 |
52 Week High | US$10,550.00 |
52 Week Low | US$4,510.00 |
Beta | 0.75 |
1 Month Change | -14.01% |
3 Month Change | -32.74% |
1 Year Change | 18.66% |
3 Year Change | 137.53% |
5 Year Change | n/a |
Change since IPO | 157.95% |
Recent News & Updates
Recent updates
Shareholder Returns
WBA | AR Consumer Retailing | AR Market | |
---|---|---|---|
7D | 2.9% | -1.6% | -4.4% |
1Y | 18.7% | -3.6% | 295.5% |
Return vs Industry: WBA exceeded the AR Consumer Retailing industry which returned -3.6% over the past year.
Return vs Market: WBA underperformed the AR Market which returned 295.5% over the past year.
Price Volatility
WBA volatility | |
---|---|
WBA Average Weekly Movement | 6.9% |
Consumer Retailing Industry Average Movement | 4.9% |
Market Average Movement | 9.5% |
10% most volatile stocks in AR Market | 14.3% |
10% least volatile stocks in AR Market | 7.2% |
Stable Share Price: WBA's share price has been volatile over the past 3 months.
Volatility Over Time: WBA's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1909 | 268,500 | Tim Wentworth | www.walgreensbootsalliance.com |
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S.
Walgreens Boots Alliance, Inc. Fundamentals Summary
WBA fundamental statistics | |
---|---|
Market cap | AR$13.71t |
Earnings (TTM) | -AR$5.26t |
Revenue (TTM) | AR$125.98t |
0.1x
P/S Ratio-2.6x
P/E RatioIs WBA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
WBA income statement (TTM) | |
---|---|
Revenue | US$144.60b |
Cost of Revenue | US$117.72b |
Gross Profit | US$26.88b |
Other Expenses | US$32.91b |
Earnings | -US$6.04b |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -7.00 |
Gross Margin | 18.59% |
Net Profit Margin | -4.18% |
Debt/Equity Ratio | 61.7% |
How did WBA perform over the long term?
See historical performance and comparison